BioTransplant


BioTransplant (BT) acquired Eligix, a developer of therapy for patients receiving bone marrow (or stem cell) transplants and related procedures to treat leukemia, lymphoma, and other diseases,

BioTransplant (BT) acquired Eligix, a developer of therapy for patients receiving bone marrow (or stem cell) transplants and related procedures to treat leukemia, lymphoma, and other diseases,

Company (Alive / Active)

All investors data 3 Investors

Phone:

Fax:

101 Washington Street Suite 101 Foxborough, MA 02035
Suite 101
 Foxborough, 02035
 Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
BioTransplant $2.4M Oct 1, 1995

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related BioTransplant Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors

Board Members

Name Firm
Login to see detailsInterWest Partners
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)